Skip to main content

Gilead Sciences, Inc.

GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000882095

In the last 90 days, Gilead Sciences, Inc. insiders filed 0 open-market purchases and 11 sales; 2,292 institutions reported holding it in 13F filings for Q2 2026, worth $140.5B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Gilead Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
11 filings
5 insiders, $15.4M in total
Insiders trading
5
Net value
−$15.4M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Gilead Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Gilead Sciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Burkhart ErinSVP, Controllership1,455Sep 23, 20262
Dickinson Andrew DChief Financial Officer164,096Sep 16, 202618
Mercier JohannaChief Comm & Corp Aff Officer116,684Sep 16, 202618
Berger DietmarChief Medical Officer19,522Sep 11, 20265
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp8,759Sep 11, 20265
O'Day Daniel PatrickChairman & CEO581,683Sep 11, 202619
Welters AnthonyDirector12,894Aug 27, 20262
Bluestone JeffreyDirector10,066Aug 21, 20264
Barton Jacqueline KDirector27,202May 4, 20261
Love Ted WDirector5,484May 4, 20261
Rodriguez JavierDirector13,364May 4, 20261
Manwani HarishDirector15,015May 4, 20261
Kramer Kelly A.Director1,339May 4, 20262
Horning SandraDirector6,293May 4, 20261
Telman Deborah HEVP, Corporate Affairs & GC43,676Nov 13, 20252
Wilfong Diane E.Interim Corp Controller & CAO46,259Sep 11, 20250
Patterson SandraSVP, Controllership39,453Mar 12, 20250
Parsey MerdadChief Medical Officer82,850Dec 11, 20240
Lofton Kevin EDirector92,653IndirectMar 29, 20240
Pletcher Brett AEVP,Corp Affairs & Gen Counsel33,426Jun 13, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2021 (view filing)Aug 171 dayWilfong Diane E.SVP, Controller & CAOSSale−13.6K$72.50−$986.7K−40.0%20.4K after
Feb 2, 2022 (view filing)Feb 11 dayPletcher Brett AEVP,Corp Affairs & Gen CounselSSale−14.1K$68.54−$963.7K−30.1%32.6K after
Feb 11, 2022 (view filing)Feb 92 daysPletcher Brett AEVP,Corp Affairs & Gen CounselSSale−1.69K$63.89−$108.0K−4.9%32.6K after
Mar 14, 2022 (view filing)Mar 113 daysPletcher Brett AEVP,Corp Affairs & Gen CounselSSale−3.63K$58.24−$211.6K−10.0%32.6K after
Nov 2, 2022 (view filing)Nov 11 dayWilfong Diane E.SVP, Controller & CAOSSale−16.3K$79.25−$1.29M−36.5%28.3K after
Nov 10, 2022 (view filing)Nov 91 dayWilfong Diane E.SVP, Controller & CAOSSale−6.42K$83.50−$535.7K−18.5%28.3K after
Jan 3, 2023 (view filing)Dec 30, 20224 daysParsey MerdadChief Medical OfficerSSale−553$85.33−$47.2K−1.2%45.6K after
Mar 2, 2023 (view filing)Mar 11 dayParsey MerdadChief Medical OfficerSSale−13.0K$79.96−$1.04M−15.6%70.1K after
Mar 14, 2023 (view filing)Mar 131 dayParsey MerdadChief Medical OfficerSSale−6.13K$78.99−$483.9K−8.0%70.1K after
Jun 14, 2023 (view filing)Jun 131 dayParsey MerdadChief Medical OfficerSSale−1.49K$76.90−$114.2K−4.8%29.4K after10b5-1
Jul 21, 2023 (view filing)Jul 201 dayDickinson Andrew DChief Financial OfficerSSale−5.00K$80.00−$400.0K−4.4%107.6K after10b5-1
Sep 13, 2023 (view filing)Sep 121 dayParsey MerdadChief Medical OfficerSSale−1.50K$76.99−$115.6K−2.1%70.1K after10b5-1
Oct 18, 2023 (view filing)Oct 171 dayDickinson Andrew DChief Financial OfficerSSale−5.00K$80.00−$400.0K−4.6%104.0K after10b5-1
Jan 10, 2024 (view filing)Jan 91 dayMercier JohannaChief Commercial OfficerSSale−8.24K$85.23−$702.5K−9.1%82.7K after10b5-1
Jan 17, 2024 (view filing)Jan 161 dayDickinson Andrew DChief Financial OfficerSSale−5.00K$85.78−$428.9K−4.7%101.5K after10b5-1
Feb 29, 2024 (view filing)Feb 28-291 dayParsey MerdadChief Medical OfficerSSale−10.2K$72.83−$745.0K−9.9%92.7K after2 lots10b5-1
Apr 2, 2024 (view filing)Apr 11 dayParsey MerdadChief Medical OfficerSSale−2.00K$72.96−$145.9K−2.0%96.3K after10b5-1
Jul 1, 2024 (view filing)Jul 1Same dayParsey MerdadChief Medical OfficerSSale−2.00K$68.63−$137.3K−2.0%96.4K after10b5-1
Aug 14, 2024 (view filing)Aug 131 dayMercier JohannaChief Commercial OfficerSSale−5.49K$73.98−$406.2K−4.6%115.0K after10b5-1
Aug 29, 2024 (view filing)Aug 281 dayMercier JohannaChief Commercial OfficerSSale−9.51K$78.03−$742.3K−8.3%105.5K after10b5-1
Sep 13, 2024 (view filing)Sep 121 dayMercier JohannaChief Commercial OfficerSSale−29.4K$83.78−$2.46M−27.3%78.1K after2 lots10b5-1
Sep 13, 2024 (view filing)Sep 121 dayParsey MerdadChief Medical OfficerSSale−21.2K$84.50−$1.80M−17.2%102.2K after10b5-1
Oct 2, 2024 (view filing)Oct 11 dayParsey MerdadChief Medical OfficerSSale−2.00K$83.83−$167.7K−2.0%100.2K after10b5-1
Nov 7, 2024 (view filing)Nov 61 dayParsey MerdadChief Medical OfficerSSale−25.6K$91.50−$2.34M−20.4%99.6K after2 lots10b5-1
Nov 7, 2024 (view filing)Nov 61 dayMercier JohannaChief Commercial OfficerSSale−5.00K$91.28−$456.4K−6.4%73.1K after10b5-1
Nov 27, 2024 (view filing)Nov 261 dayBluestone JeffreyDirectorSSale−6.79K$91.39−$620.4K−43.2%8.92K after
Nov 29, 2024 (view filing)Nov 272 daysParsey MerdadChief Medical OfficerSSale−164.2K$91.92−$15.1M−67.0%80.8K after5 lots10b5-1
Dec 3, 2024 (view filing)Nov 294 daysDickinson Andrew DChief Financial OfficerSSale−248.6K$92.76−$23.1M−64.2%138.9K after2 lots10b5-1
Dec 17, 2024 (view filing)Dec 161 dayDickinson Andrew DChief Financial OfficerSSale−8.50K$91.96−$781.7K−6.0%132.4K after10b5-1
Jan 16, 2025 (view filing)Jan 151 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$91.35−$228.4K−1.9%129.9K after10b5-1
Feb 3, 2025 (view filing)Jan 313 daysDickinson Andrew DChief Financial OfficerSSale−142.2K$97.22−$13.8M−52.3%129.9K after10b5-1
Feb 13, 2025 (view filing)Feb 121 dayDickinson Andrew DChief Financial OfficerSSale−137.7K$102.22−$14.1M−44.6%171.2K after10b5-1
Feb 19, 2025 (view filing)Feb 181 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$104.09−$260.2K−1.5%169.1K after10b5-1
Mar 12, 2025 (view filing)Mar 102 daysDickinson Andrew DChief Financial OfficerSSale−17.9K$118.17−$2.12M−9.6%169.1K after2 lots10b5-1
Mar 18, 2025 (view filing)Mar 171 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$110.53−$276.3K−1.4%170.7K after10b5-1
Apr 16, 2025 (view filing)Apr 151 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$106.40−$266.0K−1.5%168.2K after10b5-1
May 16, 2025 (view filing)May 151 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$99.82−$249.6K−1.5%165.7K after10b5-1
May 23, 2025 (view filing)May 221 dayMercier JohannaChief Commercial OfficerSSale−28.0K$107.52−$3.01M−18.8%121.2K after3 lots10b5-1
Jun 2, 2025 (view filing)May 303 daysO'Day Daniel PatrickChairman & CEOSSale−10.0K$110.41−$1.10M−1.6%620.3K after2 lots10b5-1
Jun 17, 2025 (view filing)Jun 161 dayMercier JohannaChief Commercial OfficerSSale−3.00K$110.17−$330.5K−2.4%120.2K after10b5-1
Jun 17, 2025 (view filing)Jun 161 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$110.17−$275.4K−1.5%165.1K after10b5-1
Jul 1, 2025 (view filing)Jun 301 dayO'Day Daniel PatrickChairman & CEOSSale−10.0K$110.45−$1.10M−1.6%615.7K after2 lots10b5-1
Jul 15, 2025 (view filing)Jul 141 dayBluestone JeffreyDirectorSSale−5.00K$109.74−$548.7K−35.9%8.92K after10b5-1
Jul 16, 2025 (view filing)Jul 151 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$111.03−$277.6K−1.5%162.6K after10b5-1
Jul 16, 2025 (view filing)Jul 151 dayMercier JohannaChief Commercial OfficerSSale−3.00K$111.03−$333.1K−2.5%117.2K after10b5-1
Jul 29, 2025 (view filing)Jul 281 dayO'Day Daniel PatrickChairman & CEOSSale−10.0K$113.94−$1.14M−1.6%605.7K after2 lots10b5-1
Aug 18, 2025 (view filing)Aug 153 daysMercier JohannaChief Commercial OfficerSSale−28.0K$118.53−$3.32M−19.7%114.2K after6 lots10b5-1
Aug 18, 2025 (view filing)Aug 153 daysDickinson Andrew DChief Financial OfficerSSale−2.50K$118.53−$296.3K−1.5%160.1K after10b5-1
Aug 29, 2025 (view filing)Aug 281 dayO'Day Daniel PatrickChairman & CEOSSale−10.0K$113.63−$1.14M−1.7%595.7K after10b5-1
Sep 16, 2025 (view filing)Sep 151 dayDickinson Andrew DChief Financial OfficerSSale−2.50K$113.57−$283.9K−1.5%159.6K after10b5-1